TCM

Tang Capital Management Portfolio holdings

AUM $1.98B
This Quarter Return
+49.88%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.03B
AUM Growth
+$1.03B
Cap. Flow
+$22.3M
Cap. Flow %
2.16%
Top 10 Hldgs %
93.6%
Holding
27
New
2
Increased
4
Reduced
7
Closed
6

Top Buys

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$71.7M
2
PBYI icon
Puma Biotechnology
PBYI
$5.9M
3
ANAB icon
AnaptysBio
ANAB
$5.31M
4
CHRS icon
Coherus Oncology, Inc. Common Stock
CHRS
$3.57M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
$2.62M

Top Sells

1
RLMD icon
Relmada Therapeutics
RLMD
$35.8M
2
EOLS icon
Evolus
EOLS
$13.7M
3
SGMO icon
Sangamo Therapeutics
SGMO
$4.07M
4
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$3.49M
5
RDUS
Radius Health, Inc.
RDUS
$2.47M

Sector Composition

1 Healthcare 99.31%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$596M 57.94% 14,075,269 – –
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$71.7M 6.97% +980,461 New +$71.7M
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$354M
$62.1M 6.03% 2,965,485 – –
ANAB icon
4
AnaptysBio
ANAB
$569M
$56.5M 5.49% 2,528,678 +237,851 +10% +$5.31M
HRTX icon
5
Heron Therapeutics
HRTX
$207M
$42.6M 4.14% 2,896,904 – –
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
$37M 3.6% 8,695,474 +615,129 +8% +$2.62M
BIO icon
7
Bio-Rad Laboratories Class A
BIO
$8.06B
$36.1M 3.51% 80,000 – –
UTHR icon
8
United Therapeutics
UTHR
$13.8B
$24.2M 2.35% 200,000 -8,415 -4% -$1.02M
RLMD icon
9
Relmada Therapeutics
RLMD
$37.2M
$22.4M 2.18% 500,000 -800,000 -62% -$35.8M
PBYI icon
10
Puma Biotechnology
PBYI
$254M
$14.2M 1.38% 1,365,376 +565,376 +71% +$5.9M
SGMO icon
11
Sangamo Therapeutics
SGMO
$157M
$14.1M 1.38% 1,578,795 -454,185 -22% -$4.07M
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$14M 1.36% 800,000 -200,000 -20% -$3.49M
EGRX
13
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$12.3M 1.19% 255,616 – –
CHRS icon
14
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$9.82M 0.96% 550,000 +200,000 +57% +$3.57M
LSACU
15
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
$5.5M 0.53% 500,000 – –
PRTA icon
16
Prothena Corp
PRTA
$441M
$2.86M 0.28% 273,823 -150,000 -35% -$1.57M
CTMX icon
17
CytomX Therapeutics
CTMX
$336M
$2.5M 0.24% 300,000 – –
VNDA icon
18
Vanda Pharmaceuticals
VNDA
$279M
$2.19M 0.21% 191,426 -108,374 -36% -$1.24M
RDUS
19
DELISTED
Radius Health, Inc.
RDUS
$1.62M 0.16% 119,005 -180,995 -60% -$2.47M
NCNA
20
NuCana
NCNA
$6.09M
$541K 0.05% 100,000 – –
TENX icon
21
Tenax Therapeutics
TENX
$27.3M
$416K 0.04% +460,000 New +$416K
ENTA icon
22
Enanta Pharmaceuticals
ENTA
$180M
– – -13,483 Closed -$693K
EOLS icon
23
Evolus
EOLS
$494M
– – -3,295,000 Closed -$13.7M
UPS icon
24
United Parcel Service
UPS
$74.1B
– – -1,000 Closed -$93K
CMRX
25
DELISTED
Chimerix, Inc.
CMRX
– – -431,273 Closed -$621K
1
2